Genovese Burford & Brothers Wealth & Retirement Plan Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17	Closed	-$5K	–	119
2018 Q2	$5K	Hold	17	–	–	﹤0.01%	353
2018 Q1	$4K	Hold	17	–	–	﹤0.01%	372
2017 Q4	$5K	Hold	17	–	–	0.01%	205
2017 Q3	$3K	Buy	+17	New	+$3.83K	﹤0.01%	353

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's BIO Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2018, closing a stake of 17 shares — an estimated $5K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in BIO in Q3 2017 and held it in 4 quarters. The position peaked at $5K in Q2 2018. 344 funds tracked by Wall St. Rank hold BIO as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 17 Bio-Rad Laboratories Class A shares in Q3 2018, an estimated $5K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Bio-Rad Laboratories Class A in Q3 2017 and held it in 4 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Bio-Rad Laboratories Class A position peaked at $5K in Q2 2018.
344 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.